NYSE · Consulting Services

Franklin Covey Company (FC) Stock

$17.95 -1.16% NYSE: FC Industrials

Valuation

MetricValue
Price$17.95
Market Cap$202.73M
P/E Ratio96.28
P/B Ratio4.54
P/S Ratio0.74
EPS (TTM)$0.24
52-Week High$26.81
52-Week Low$11.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE4.33%
ROA1.10%
ROCE20.88%
Gross Margin2.25%
Operating Margin2.25%
Net Margin0.83%
Debt/Equity0.12
Current Ratio0.82

Annual Financials (USD)

Metric20212022202320242025
Revenue$224.0M$263.0M$281.0M$287.0M$267.0M
Operating Profit$8.0M$24.0M$26.0M$33.0M$6.0M
Net Profit$14.0M$18.0M$18.0M$23.0M$3.0M
EPS$0.96$1.27$1.24$1.74$0.24
Op Margin3.6%9.0%9.4%11.5%2.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$250.0M$259.0M$246.0M$262.0M$243.0M
Total Liabilities$170.0M$176.0M$167.0M$178.0M$176.0M
Cash$47.0M$61.0M$38.0M$49.0M$32.0M
Borrowings$33.0M$24.0M$15.0M$6.0M$8.0M

Latest News

Why Franklin Covey Stock Plummeted Today Motley Fool · Jul 2, 2026 Sector Update: Consumer Stocks Mixed Late Afternoon MT Newswires · Jul 2, 2026 Top Premarket Decliners MT Newswires · Jul 2, 2026 FC Q3 Earnings Call Points to Stronger 2027 Setup Zacks · Jul 2, 2026 Update: Franklin Covey Drops Premarket as Cut to FY2026 Sales Outlook Chips Away at Fiscal Q3 Results MT Newswires · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$46.0M$52.0M$36.0M$60.0M$29.0M
Investing Cash Flow$-18.0M$-11.0M$-27.0M$-15.0M$-34.0M
Financing Cash Flow$-5.0M$-25.0M$-36.0M$-34.0M$-26.0M
Net Cash Flow$20.0M$13.0M$-22.0M$10.0M$-17.0M
Free Cash Flow$42.0M$47.0M$22.0M$57.0M$12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.90
EV / EBITDA12.39
FCF Yield8.80%
Quick Ratio0.61
Interest Coverage50.14
Return 1Y0.24%
Return 3Y-53.86%
Return 5Y-42.51%

Ownership

Insiders Held18.62%
Institutions Held74.80%
Institutions Float Held91.91%
Institutional HolderSharesReport Date
Alliancebernstein L.P.1,055,2622026-03-31
Royce & Associates LP1,042,7102026-03-31
Blackrock Inc.925,7182026-03-31
Rice, Hall, James & Associates LLC510,6892026-03-31
Vanguard Capital Management LLC467,5582026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALTGAlta Equipment Group Inc. $5.94 -1.49% -2.37 $194.04M 0.00%
DSXDiana Shipping inc. $2.50 -2.34% 5.88 $311.03M 1.40%
FORRForrester Research, Inc. $11.75 -1.55% -5.01 $223.71M 0.00%
GENCGencor Industries, Inc. $17.81 +0.45% 17.44 $261.05M 0.00%
PAMTPAMT CORP $11.59 -3.01% -6.03 $242.72M 0.00%

About Franklin Covey Company

Franklin Covey Company is led by CEO Paul S. Walker, employs 1,084 people, headquartered in US, publicly traded since 1992.

Franklin Covey Company (FC) stock trades at $17.95 with a market capitalization of $202.73M. The stock is valued at a price-to-earnings (P/E) ratio of 96.28, price-to-book of 4.54, price-to-sales of 0.74. Over the past 52 weeks the stock has ranged between $11.16 and $26.81, and currently trades 33.0% below its 52-week high.

On profitability, Franklin Covey Company generates a return on equity (ROE) of 4.33%, return on capital employed of 20.88%, an operating margin of 2.25%, a net profit margin of 0.83%.

Related Industrials Stocks

SPCX Space Exploration Technologies Corp. $146.03 -1.74% CAT Caterpillar, Inc. $730.76 -0.66% GE GE Aerospace $313.83 +0.59% RTX RTX Corporation $193.92 +3.73% DE Deere & Company $641.86 -1.35% UNP Union Pacific Corporation $289.04 +0.11% ETN Eaton Corporation, PLC $391.25 -2.79% BA Boeing Company (The) $190.21 +0.78% LMT Lockheed Martin Corporation $552.09 +3.65% PH Parker-Hannifin Corporation $963.34 +0.17% ADP Automatic Data Processing, Inc. $288.90 +1.14% TT Trane Technologies plc $458.89 +0.33%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Industrials StocksLow P/E Industrials StocksHigh Net Margin Industrials StocksDividend Industrials StocksLow Debt Industrials StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.